Masimo (BSP:M2AS34) Tariff Resilience Score: 7/10 (As of Jun. 26, 2026)


BSP:M2AS34 Masimo Corp BSP:M2AS34
55 GF Score
Price R$39.00
GF Value R$36.87
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Masimo Tariff Resilience Score?

Masimo BSP:M2AS34 +27.16% 55 Tariff Resilience Score is 7 as of Jun. 26, 2026. GuruFocus rates BSP:M2AS34 with a GF Score™ of 55/100 and a GF Value™ of R$36.87 (Fairly Valued). The stock has 9 warning signs investors should review. Among 838 Medical Devices & Instruments companies, Masimo ranks better than 98.09% on this metric.

Masimo has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Masimo has Masimo's medical devices are primarily manufactured in the U.S. with a global sales market. Limited exposure to tariffs due to industry-specific exemptions and strong pricing power. Historical impacts have been minimal.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Masimo might have Highly Resilient.

Masimo  (BSP:M2AS34) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Masimo Tariff Resilience Score Related Terms

BSP:M2AS34 vs BRKR, PODD, BIO: Tariff Resilience Score Comparison

For the Medical Devices subindustry, Masimo's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Masimo Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Masimo's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Masimo's Tariff Resilience Score falls into.


BSP:M2AS34
55GF Score
Masimo Corp BSP:M2AS34
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
Masimo (BSP:M2AS34) has a Tariff Resilience Score of 7 as of Jun. 26, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Masimo ranks #16 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 1.9%.
Is Masimo's Tariff Resilience Score too high?
Masimo's current Tariff Resilience Score is 7. Based on the distribution chart, Masimo ranks #16 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Masimo has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Masimo's Tariff Resilience Score compare to BRKR and PODD?
According to the Medical Devices & Instruments industry distribution chart, Masimo ranks #16 out of 838 companies for Tariff Resilience Score. This places Masimo in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Masimo's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Masimo stock overvalued right now?
Based on GuruFocus' analysis, Masimo (BSP:M2AS34) is currently considered Fairly Valued. The stock's GF Value™ is R$36.87, compared to a current price of R$39.00 — trading 5.8% above its estimated fair value. The current Tariff Resilience Score is 7. Masimo's overall GF Score™ is 55/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Masimo (BSP:M2AS34), the current Tariff Resilience Score is 7 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Masimo (BSP:M2AS34) Overvalued in 2026?

Based on GuruFocus' analysis, Masimo stock appears to be overvalued. The current stock price of R$39.00 is trading 5.8% above its estimated GF Value™ of R$36.87. GuruFocus considers Masimo to be Fairly Valued.

Key valuation signals for BSP:M2AS34:

  • Tariff Resilience Score: 7
  • GF Value™: R$36.87 vs. price of R$39.00 (5.8% above fair value)
  • GF Score™: 55/100 with 9 warning signs

No single metric tells the full story. See the BSP:M2AS34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Masimo Business Description

Address 52 Discovery, Irvine, CA, USA, 92618
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
55GF Score

Get the complete analysis for BSP:M2AS34

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$39.00
Price
R$36.87
GF Value